Skip to main content
. 2011 Oct 17;6:65. doi: 10.1186/1750-1172-6-65

Table 5.

Novel intronic variants

Nucleotide change Intron Predicted pathology No. of alleles
c.1328 + 52T > C IVS7 - 3

c.1841-61G > A IVS10 - 11

c.4627 + 32G > T IVS21 UV2 1

c.6485 + 18C > T IVS33 UV2 1

c.6486-54T > C IVS33 UV2 2

c.6486-43T > A IVS33 UV2 1

c.6657 + 29C > A IVS34 UV2 1

c.8681 + 18A > G IVS43 UV2 1

c.8681 + 53T > G IVS43 UV2 1

c.8681 + 118A > G IVS43 UV2 1

c.9056-52G > T IVS45 UV 1

c.9372-50A > G IVS47 UV2 1

c.9740-59G > A IVS49 UV2 1

c.9958 + 128A > G IVS50 - 4

c.10388-123T > C IVS52 UV2 1

c.13812-78A > G IVS63 UV2 1

c.14134-53T > C IVS64 UV2 1

c.14343 + 36G > C IVS65 UV2 1

c.15298-35T > A IVS70 UV2 1

c.15298-1153G > A(g.798209G > A) d IVS71 UV2 1

UV2: probably non- pathogenic mutations; - : neutral variants.

No. of alleles: Number of alleles identified in patients.

dThe intronic variant g.798209G > A affects the last nucleotide of the cochlea specific exon 71. g.DNA numbering starts at nucleotide position 1 in Human Refseq: NG_009497.1 GI:222352133, which represents the minus (-) strand of USH2A.